Tag: Cancer: Rectal
Additional Benefit Seen for Colonoscopy Versus Sigmoidoscopy
In recent study, fewer CRC cases and deaths per 100,000 person-years were observed
Fecal Occult Blood Testing Tied to Reduction in Colorectal Cancer Mortality
Findings show 14 percent decreased colorectal cancer mortality over 14 years
Multitarget Fecal Immunochemical Test Increases Detection of Advanced Adenoma
mtFIT-based screening could reduce incidence of colorectal cancer by 21 percent and associated mortality by 18 percent
Overall Decline in Cancer Deaths Expected in Europe in 2024
However, experts predict rise in colorectal cancer deaths in younger adults
ctDNA-Based Detection of Residual Disease Prognostic for Resected CRC
ctDNA-based detection of molecular residual disease in response to adjuvant chemotherapy prognostic of outcomes
Robotic Surgery Preferred for Most Colorectal Cancer Surgeries
Advantage not seen for robotic low anterior resection, which has increased risk for serious complications
Beans Beneficial for Patients With History of Colorectal Neoplasia
Increase in diversity and shifts in multiple bacteria, including Faecalibacterium, indicative of prebiotic efficacy on intervention
MSI-H Colorectal Cancer Rarely Recurs After Immunotherapy Cessation
88 percent of 64 patients remained without disease progression after median of 22.6 months after stopping immunotherapy
Risk for CRC Reduced With GLP-1RAs for Drug-Naive Patients With T2D
GLP-1 receptor agonists linked to reduced risk for CRC compared with other antidiabetics, including insulin and metformin
Colorectal Screening Rates Do Not Differ by 10-Year Life Expectancy in Seniors
Authors say that screening based on individual life expectancy, rather than age, may improve screening selection and value